Ashley Marie Twyman, MD | |
2500 Ne Neff Rd, Bend, OR 97701-6015 | |
(541) 706-6892 | |
(541) 706-6813 |
Full Name | Ashley Marie Twyman |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 6 Years |
Location | 2500 Ne Neff Rd, Bend, Oregon |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003311291 | NPI | - | NPPES |
7100608810 | Medicaid | KY |
Facility Name | Location | Facility Type |
---|---|---|
Providence St Vincent Medical Center | Portland, OR | Hospital |
Ut Southwestern University Hospital - William P. Clements Jr. | Dallas, TX | Hospital |
Providence Portland Medical Center | Portland, OR | Hospital |
St Charles Medical Center - Bend | Bend, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Charles Health System Inc | 3870402852 | 150 |
University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
The Lieber Institute for Brain Development (LIBD) announces significant advances in identifying the causes of schizophrenia and related developmental brain disorders and translating these findings into new treatment strategies.
A consortium of Louisiana's leading biomedical research institutions, headed by the Pennington Biomedical Research Center, partnered with LSU and Tulane Health Science Centers in New Orleans, will investigate the mysteries of "long COVID" under a National Institutes of Health award.
The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).
Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).
› Verified 3 days ago
Entity Name | Providence Health & Services Oregon |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003991845 PECOS PAC ID: 5395656284 Enrollment ID: O20031113000626 |
News Archive
The Lieber Institute for Brain Development (LIBD) announces significant advances in identifying the causes of schizophrenia and related developmental brain disorders and translating these findings into new treatment strategies.
A consortium of Louisiana's leading biomedical research institutions, headed by the Pennington Biomedical Research Center, partnered with LSU and Tulane Health Science Centers in New Orleans, will investigate the mysteries of "long COVID" under a National Institutes of Health award.
The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).
Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).
› Verified 3 days ago
Entity Name | Providence Health & Services Oregon |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114015971 PECOS PAC ID: 9335057447 Enrollment ID: O20031117000153 |
News Archive
The Lieber Institute for Brain Development (LIBD) announces significant advances in identifying the causes of schizophrenia and related developmental brain disorders and translating these findings into new treatment strategies.
A consortium of Louisiana's leading biomedical research institutions, headed by the Pennington Biomedical Research Center, partnered with LSU and Tulane Health Science Centers in New Orleans, will investigate the mysteries of "long COVID" under a National Institutes of Health award.
The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).
Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).
› Verified 3 days ago
Entity Name | Providence Health & Services Oregon |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093976243 PECOS PAC ID: 3476450560 Enrollment ID: O20031217000186 |
News Archive
The Lieber Institute for Brain Development (LIBD) announces significant advances in identifying the causes of schizophrenia and related developmental brain disorders and translating these findings into new treatment strategies.
A consortium of Louisiana's leading biomedical research institutions, headed by the Pennington Biomedical Research Center, partnered with LSU and Tulane Health Science Centers in New Orleans, will investigate the mysteries of "long COVID" under a National Institutes of Health award.
The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).
Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).
› Verified 3 days ago
Entity Name | St Charles Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982621447 PECOS PAC ID: 3870402852 Enrollment ID: O20040112000045 |
News Archive
The Lieber Institute for Brain Development (LIBD) announces significant advances in identifying the causes of schizophrenia and related developmental brain disorders and translating these findings into new treatment strategies.
A consortium of Louisiana's leading biomedical research institutions, headed by the Pennington Biomedical Research Center, partnered with LSU and Tulane Health Science Centers in New Orleans, will investigate the mysteries of "long COVID" under a National Institutes of Health award.
The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).
Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).
› Verified 3 days ago
Entity Name | Providence Health & Services Oregon |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366536963 PECOS PAC ID: 6103728753 Enrollment ID: O20040123000371 |
News Archive
The Lieber Institute for Brain Development (LIBD) announces significant advances in identifying the causes of schizophrenia and related developmental brain disorders and translating these findings into new treatment strategies.
A consortium of Louisiana's leading biomedical research institutions, headed by the Pennington Biomedical Research Center, partnered with LSU and Tulane Health Science Centers in New Orleans, will investigate the mysteries of "long COVID" under a National Institutes of Health award.
The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).
Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).
› Verified 3 days ago
Entity Name | Providence Health & Services Oregon |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952482275 PECOS PAC ID: 3072415652 Enrollment ID: O20040123000519 |
News Archive
The Lieber Institute for Brain Development (LIBD) announces significant advances in identifying the causes of schizophrenia and related developmental brain disorders and translating these findings into new treatment strategies.
A consortium of Louisiana's leading biomedical research institutions, headed by the Pennington Biomedical Research Center, partnered with LSU and Tulane Health Science Centers in New Orleans, will investigate the mysteries of "long COVID" under a National Institutes of Health award.
The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).
Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).
› Verified 3 days ago
Entity Name | Providence Health & Services Oregon |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568547503 PECOS PAC ID: 5294623245 Enrollment ID: O20040310000315 |
News Archive
The Lieber Institute for Brain Development (LIBD) announces significant advances in identifying the causes of schizophrenia and related developmental brain disorders and translating these findings into new treatment strategies.
A consortium of Louisiana's leading biomedical research institutions, headed by the Pennington Biomedical Research Center, partnered with LSU and Tulane Health Science Centers in New Orleans, will investigate the mysteries of "long COVID" under a National Institutes of Health award.
The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).
Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).
› Verified 3 days ago
Entity Name | Providence Health & Services - Oregon |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912282369 PECOS PAC ID: 5294901922 Enrollment ID: O20120319000430 |
News Archive
The Lieber Institute for Brain Development (LIBD) announces significant advances in identifying the causes of schizophrenia and related developmental brain disorders and translating these findings into new treatment strategies.
A consortium of Louisiana's leading biomedical research institutions, headed by the Pennington Biomedical Research Center, partnered with LSU and Tulane Health Science Centers in New Orleans, will investigate the mysteries of "long COVID" under a National Institutes of Health award.
The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).
Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Ashley Marie Twyman, MD Po Box 845347, Dallas, TX 75284-7208 Ph: (214) 645-3597 | Ashley Marie Twyman, MD 2500 Ne Neff Rd, Bend, OR 97701-6015 Ph: (541) 706-6892 |
News Archive
The Lieber Institute for Brain Development (LIBD) announces significant advances in identifying the causes of schizophrenia and related developmental brain disorders and translating these findings into new treatment strategies.
A consortium of Louisiana's leading biomedical research institutions, headed by the Pennington Biomedical Research Center, partnered with LSU and Tulane Health Science Centers in New Orleans, will investigate the mysteries of "long COVID" under a National Institutes of Health award.
The Louisville Courier Journal: "While private Medicare Advantage plans face funding pressure from Washington, Medicare 'is actually a very good place to be,' the chief executive of Louisville-based Humana said. 'The federal government "can be relied upon to pay their bills," Michael McCallister said at the Bernstein Strategic Decisions investor conference. 'Medicare is going to be a very big business in the future'"(6/5).
Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).
› Verified 3 days ago
Kevin Ducey, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 503-494-8211 | |
Lori Ann Beireis, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 Fax: 541-706-6813 | |
Dr. David Eric Barnett, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-382-4321 | |
Dr. Victor A Nwanguma, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1501 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-706-6532 | |
Dr. Jeffrey Spencer Chen, MD, PHD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-5811 Fax: 541-706-5867 | |
Ann Elisabeth Kellogg, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-382-4321 | |
Jennifer R Ashley, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-5811 Fax: 541-706-5867 |